We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » TRAIN SALES REPS TO AVOID ASP MARKETING RISK, EXPERT WARNS
TRAIN SALES REPS TO AVOID ASP MARKETING RISK, EXPERT WARNS
March 29, 2004
Part of the goal of policymakers in discarding the average wholesale price (AWP) reimbursement mechanism when they adopted the recent Medicare Rx legislation was to stop drugmakers from marketing the spread between AWP and acquisition costs, but the new average sales price (ASP) reimbursement mechanism creates a new potential for marketing the spread.